Edesa Biotech, Inc. (EDSA) › Capital ExpendituresEdesa Biotech, Inc. (EDSA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $78.3K2013: $9.5K2014: $279.1K2015: $274.6K2016: $402.3K2017: $302.7K2018: $6.9K2020: $4.9K2021: $6.1K2022: $5.7K2023: $0$02012Capital Expenditures (USD)2023Fiscal YearCapital ExpendituresChange YoY2023$0-100.0%2022$5.7K-8.0%2021$6.1K+26.6%2020$4.9K—2018$6.9K-97.7%2017$302.7K-24.7%2016$402.3K+46.5%2015$274.6K-1.6%2014$279.1K+2824.9%2013$9.5K-87.8%2012$78.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share